• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近年来,开发具有轴手性的生物活性化合物方面取得了进展。

Recent progress toward developing axial chirality bioactive compounds.

机构信息

Department of Medical Experimental Center, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.

Department of Pharmacy, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.

出版信息

Eur J Med Chem. 2022 Dec 5;243:114700. doi: 10.1016/j.ejmech.2022.114700. Epub 2022 Aug 28.

DOI:10.1016/j.ejmech.2022.114700
PMID:36058089
Abstract

Atropisomers are stereoisomers with axial chirality arising from restricted rotation around a single bond. Lots of representatives of this class of axially chiral compounds exhibit remarkable biological properties for protein targets. This time-dependent chirality shows great potential for drug development. Herein, we comprehensively review axial chirality bioactive compounds, including C-C bonded atropisomers, C-N bonded atropisomers, and N-N bonded atropisomers. Examples of each are provided along with their biological activity. This review highlights the development of various examples of atropisomerism encountered in bioactive compounds, which is beneficial for medicinal chemists to advance atropisomeric drug molecules.

摘要

手性轴化合物是由单键旋转受限而产生轴手性的立体异构体。这一类手性轴化合物的许多代表物对蛋白质靶标表现出显著的生物学特性。这种时变手性在药物开发方面具有巨大的潜力。本文全面综述了轴手性生物活性化合物,包括 C-C 键合的轴手性化合物、C-N 键合的轴手性化合物和 N-N 键合的轴手性化合物。每个化合物都提供了示例及其生物活性。本综述强调了在生物活性化合物中遇到的各种轴手性化合物的发展,这有利于药物化学家推进轴手性药物分子的发展。

相似文献

1
Recent progress toward developing axial chirality bioactive compounds.近年来,开发具有轴手性的生物活性化合物方面取得了进展。
Eur J Med Chem. 2022 Dec 5;243:114700. doi: 10.1016/j.ejmech.2022.114700. Epub 2022 Aug 28.
2
Recent encounters with atropisomerism in drug discovery.药物研发中近期遇到的阻转异构现象。
Bioorg Med Chem Lett. 2018 Jan 15;28(2):53-60. doi: 10.1016/j.bmcl.2017.11.050. Epub 2017 Dec 6.
3
Atropisomerism in Drug Discovery: A Medicinal Chemistry Perspective Inspired by Atropisomeric Class I PI3K Inhibitors.手性药物发现中的对映异构体现象:受手性 Class I PI3K 抑制剂启发的药物化学观点。
Acc Chem Res. 2022 Sep 20;55(18):2581-2593. doi: 10.1021/acs.accounts.2c00485. Epub 2022 Sep 7.
4
Approaches to Synthesis and Isolation of Enantiomerically Pure Biologically Active Atropisomers.对映体纯生物活性非对映异构体的合成与分离方法。
Acc Chem Res. 2022 Oct 18;55(20):2938-2948. doi: 10.1021/acs.accounts.2c00513. Epub 2022 Oct 4.
5
Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery.生物活性阻转异构体:揭示药物发现的设计策略与合成路线
Med Res Rev. 2024 Sep;44(5):1971-2014. doi: 10.1002/med.22037. Epub 2024 Mar 21.
6
Atropisomerism in the Pharmaceutically Relevant Realm.手性在药物相关领域的研究进展。
Acc Chem Res. 2022 Oct 18;55(20):2904-2919. doi: 10.1021/acs.accounts.2c00500. Epub 2022 Sep 26.
7
Revealing atropisomer axial chirality in drug discovery.揭示药物发现中的轴手性对映体。
ChemMedChem. 2011 Mar 7;6(3):505-13. doi: 10.1002/cmdc.201000485. Epub 2011 Jan 5.
8
Catalytic Asymmetric Synthesis of Atropisomers Bearing Multiple Chiral Elements: An Emerging Field.具有多个手性元素的阻转异构体的催化不对称合成:一个新兴领域。
Angew Chem Int Ed Engl. 2024 Jan 15;63(3):e202311053. doi: 10.1002/anie.202311053. Epub 2023 Nov 21.
9
Addressing Atropisomerism in the Development of Sotorasib, a Covalent Inhibitor of KRAS G12C: Structural, Analytical, and Synthetic Considerations.解决 Sotorasib(一种 KRAS G12C 的共价抑制剂)中立体异构现象的问题:结构、分析和合成方面的考虑。
Acc Chem Res. 2022 Oct 18;55(20):2892-2903. doi: 10.1021/acs.accounts.2c00479. Epub 2022 Sep 30.
10
Atropisomerism in medicinal chemistry: challenges and opportunities.手性药物化学中的对映异构现象:挑战与机遇。
Future Med Chem. 2018 Feb;10(4):409-422. doi: 10.4155/fmc-2017-0152. Epub 2018 Jan 30.

引用本文的文献

1
-TEtraQuinoline (-TEQ): an inherently chiral N4 macrocyclic quinoline tetramer.-四喹啉(-TEQ):一种具有固有手性的N4大环喹啉四聚体。
Chem Sci. 2025 May 20;16(24):10714-10721. doi: 10.1039/d5sc02937f. eCollection 2025 Jun 18.
2
Organocatalytic atroposelective construction of monoaxially and 1,4-diaxially chiral fused uracils with potential antitumor activity.具有潜在抗肿瘤活性的单轴和1,4 - 二轴手性稠合尿嘧啶的有机催化对映选择性构建
Chem Sci. 2025 Mar 28;16(18):7876-7883. doi: 10.1039/d5sc00452g. eCollection 2025 May 7.
3
Enantio-, atrop-, and diastereoselective macrolactonization to access type III cyclophanes.
对映选择性、非对映选择性和非对映选择性大环内酯化反应以合成III型环芳烷。
Nat Commun. 2025 Apr 3;16(1):3170. doi: 10.1038/s41467-025-58241-3.
4
Synthesis of Novel Planar-Chiral Charge-Compensated -Carborane-Based Amino Acid.新型平面手性电荷补偿的基于碳硼烷的氨基酸的合成
Molecules. 2024 Sep 21;29(18):4487. doi: 10.3390/molecules29184487.
5
Atroposelective Synthesis of Biaryl N-Oxides via Cu-Catalyzed De Novo Heteroaromatic N-Oxide Ring Formation.通过铜催化从头构建杂芳烃 N-氧化物环反应实现对映选择性合成联芳基 N-氧化物。
Adv Sci (Weinh). 2024 Oct;11(40):e2405743. doi: 10.1002/advs.202405743. Epub 2024 Aug 9.
6
The therapeutic efficacy of different configuration nano-polydopamine drug carrier systems with photothermal synergy against head and neck squamous cell carcinoma.不同构型具有光热协同作用的纳米聚多巴胺药物载体系统对头颈部鳞状细胞癌的治疗效果
Regen Biomater. 2024 Jun 20;11:rbae073. doi: 10.1093/rb/rbae073. eCollection 2024.
7
Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity.轴向手性大麻素:设计、合成与大麻素受体亲和力。
J Am Chem Soc. 2023 Jun 28;145(25):13581-13591. doi: 10.1021/jacs.3c00129. Epub 2023 Jun 14.
8
Desymmetrization of Prochiral -Pyrazolyl Maleimides via Organocatalyzed Asymmetric Michael Addition with Pyrazolones: Construction of Tri--Heterocyclic Scaffolds Bearing Both Central and Axial Chirality.通过手性吡唑啉酮参与的有机催化不对称迈克尔加成反应对前手性-吡唑基马来酰亚胺进行去对称化:构建同时具有中央和轴向手性的三杂环骨架。
Molecules. 2023 May 23;28(11):4279. doi: 10.3390/molecules28114279.
9
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study.Elagolix 钠盐及其合成中间体的光谱学、晶体学和构象研究。
Molecules. 2023 May 3;28(9):3861. doi: 10.3390/molecules28093861.
10
DBU Promoted Polysubstituted Arene Formation via a Michael Addition/Cyclization/Elimination Cascade Reaction.DBU 通过迈克尔加成/环化/消除级联反应促进多取代芳烃的形成。
Molecules. 2022 Nov 23;27(23):8167. doi: 10.3390/molecules27238167.